MatOrtho received approval under the CE Mark for ReCerf Hip Resurfacing Arthroplasty (HRA).
ReCerf is reportedly the world’s first commercially available ceramic HRA, first approved by Australia’s Therapeutic Goods Administration in 2024. Since its initial use in 2018, over 1,600 patients have received the device. Patient-reported outcomes are highly positive, and the revision rate remains very low up to six years.
Made from BIOLOX delta ceramic, ReCerf offers an alternative to metal-on-metal bearings and preserves more of the patient’s natural bone.
ReCerf’s availability under CE marking is matched by a strong commitment to responsible adoption. MatOrtho supports structured education, careful patient selection, and ongoing clinical monitoring. A peer-led surgeon training programme is already in place to ensure safe and effective use.
“This is more than a regulatory milestone. It represents two decades of focused effort to improve hip resurfacing through an advanced material,” said Mike Tuke, Founder of MatOrtho. “That became a possibility with BIOLOX delta and cooperation with CeramTec, which led in stages to ReCerf – an all-ceramic resurfacing implant that is already delivering excellent results. We’re proud to make this more widely available to specialist hip resurfacing surgeons, and patients who want to stay active.”
MatOrtho received approval under the CE Mark for ReCerf Hip Resurfacing Arthroplasty (HRA).
ReCerf is reportedly the world's first commercially available ceramic HRA, first approved by Australia's Therapeutic Goods Administration in 2024. Since its initial use in 2018, over 1,600 patients have received the device. Patient-reported outcomes...
MatOrtho received approval under the CE Mark for ReCerf Hip Resurfacing Arthroplasty (HRA).
ReCerf is reportedly the world’s first commercially available ceramic HRA, first approved by Australia’s Therapeutic Goods Administration in 2024. Since its initial use in 2018, over 1,600 patients have received the device. Patient-reported outcomes are highly positive, and the revision rate remains very low up to six years.
Made from BIOLOX delta ceramic, ReCerf offers an alternative to metal-on-metal bearings and preserves more of the patient’s natural bone.
ReCerf’s availability under CE marking is matched by a strong commitment to responsible adoption. MatOrtho supports structured education, careful patient selection, and ongoing clinical monitoring. A peer-led surgeon training programme is already in place to ensure safe and effective use.
“This is more than a regulatory milestone. It represents two decades of focused effort to improve hip resurfacing through an advanced material,” said Mike Tuke, Founder of MatOrtho. “That became a possibility with BIOLOX delta and cooperation with CeramTec, which led in stages to ReCerf – an all-ceramic resurfacing implant that is already delivering excellent results. We’re proud to make this more widely available to specialist hip resurfacing surgeons, and patients who want to stay active.”
Copy to clipboard 
